Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A Pair Of GEMS: PTC Unveils Two Platform-Based Deals In One Day

This article was originally published in The Pink Sheet Daily

Executive Summary

PTC will collaborate with Roche in CNS discovery efforts, while Celgene exercises an option on work done on an oncology target.

You may also be interested in...



Roche Inks A Second Deal With PTC Therapeutics, Pays $30M Upfront

The Big Pharma teams up with a biotech and a patient advocacy foundation to develop treatments for a rare genetic disorder.

AstraZeneca Digs For GEMS In Discovery Deal With PTC

The UK big pharma is the latest to strike deal with PTC for access to its drug discovery platform, this time in oncology.

AstraZeneca Digs For GEMS In Discovery Deal With PTC

The UK big pharma is the latest to strike deal with PTC for access to its drug discovery platform, this time in oncology.

Topics

UsernamePublicRestriction

Register

ID1122310

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel